早期补充维生素A改善极早产儿视网膜病变的结局
这项随机对照研究纳入262例极早产儿,132例分入维生素A组、130例分入对照组,维生素A组自开始微量喂养起经肠内喂养给予维生素A 1500 IU/天,持续28天或至出院。结果显示维生素A组1型视网膜病变未调整发生率低于对照组(1.6% vs 6.9%,P=0.030),支气管肺发育不良发生率亦低于对照组(18.9% vs 33.8%,P=0.008),未报告维生素A毒性或颅内压升高。
要点
- 维生素A组1型视网膜病变未调整发生率为1.6%,低于对照组的6.9%(P=0.030)。
- 维生素A组支气管肺发育不良发生率为18.9%,低于对照组的33.8%(P=0.008)。
- 未报告维生素A毒性或颅内压升高征象;补充后第14天、第28天及矫正胎龄36周血清维生素A高于安慰剂组(P<0.001)。
核心结论
- 补充维生素A减少了极早产儿的维生素A缺乏,与1型视网膜病变发生率降低相关,并可能对减少支气管肺发育不良有正面影响。
研究设计与样本
- 随机对照研究,共262例符合条件的极早产儿接受随机分组,其中132例分入维生素A组、130例分入对照组。
- 维生素A组经肠内喂养给予维生素A溶液1500 IU/天,自开始微量喂养时即加入,持续28天或至出院。
主要发现
- 补充维生素A的婴儿在第14天、第28天及矫正胎龄36周时的血清维生素A高于安慰剂组(P<0.001)。
- 未报告维生素A毒性或颅内压升高的征象。
- 维生素A组1型视网膜病变未调整发生率为1.6%,对照组为6.9%(P=0.030)。
- 维生素A组支气管肺发育不良未调整发生率为18.9%,对照组为33.8%(P=0.008)。
- 回归分析显示血清维生素A水平与1型视网膜病变风险之间存在关联(beta=-2.37)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study assessed the efficacy and safety of early vitamin A (VA) supplementation to improve outcomes of retinopathy of prematurity in extremely preterm infants. METHODS: A total of 262 eligible extremely preterm infants underwent randomization; of these, 132 were assigned to the VA group and 130 to the control group. The infants were administered a solution of VA (1,500 IU/day), added to their enteral feeds as soon as minimal feeding was introduced and continued for 28 days or until discharge. RESULTS: With no adverse effects occurring, serum VA of the VA-supplemented infants on Days 14, 28, and postmenstrual 36 weeks was higher than that of the placebo group (P < 0.001). No signs of VA toxicity or increased intracranial pressure were reported. The VA group had lower unadjusted rates of Type 1 retinopathy of prematurity (1.6 vs. 6.9%, P = 0.030) and bronchopulmonary dysplasia (18.9 vs. 33.8%, P = 0.008) than the control group. Regression analysis revealed an association between serum VA levels and risk of Type 1 retinopathy of prematurity (beta = -2.37). CONCLUSION: Vitamin A supplementation reduced VA deficiency in extremely preterm infants; it was associated with a decreased incidence of Type 1 retinopathy of prematurity and may also have a positive impact on reducing bronchopulmonary dysplasia.
引用
- Sun H, Cheng R, Wang Z, et al. EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS. Retina. 2020. PMID: 30964778. doi:10.1097/IAE.0000000000002543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。